Cellceutix Matriculates to Harvard
http://www.valuewalk.com/2011/11/cellceutix-matriculates-harvard/ Note I will be posting an interview with the CEO next week, where we will discuss more about the company and valuation. Stay tuned!...
View ArticleInterview With CEO Of Cellceutix Corporation: Leo Ehrlich
Seth Klarman invests in very interesting biotechs, that probably no one can value to besides him. I found an interesting biotech that has clinical trials coming up with the Dana Farber/Harvard Cancer...
View ArticleCellceutix CEO, and Advisor Jim Boeheim Interviewed by Boston Herald About...
BEVERLY, MA–(Marketwire -06/04/12)- Cellceutix Corporation (CTIX) (the “Company”), a biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including...
View Article
More Pages to Explore .....
